These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33795792)

  • 41. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.
    Dani C; Poggi C; Mosca F; Schena F; Lista G; Ramenghi L; Romagnoli C; Salvatori E; Rosignoli MT; Lipone P; Comandini A
    Trials; 2016 Apr; 17():182. PubMed ID: 27038924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants.
    Dani C; Poggi C; Cianchi I; Corsini I; Vangi V; Pratesi S
    Eur J Pediatr; 2018 Apr; 177(4):533-539. PubMed ID: 29372379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety.
    Olgun H; Ceviz N; Kartal İ; Caner İ; Karacan M; Taştekin A; Becit N
    Pediatr Neonatol; 2017 Feb; 58(1):29-35. PubMed ID: 27238078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial.
    Sosenko IR; Fajardo MF; Claure N; Bancalari E
    J Pediatr; 2012 Jun; 160(6):929-35.e1. PubMed ID: 22284563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study.
    Dani C; Vangi V; Bertini G; Pratesi S; Lori I; Favelli F; Ciuti R; Bandinelli A; Martano C; Murru P; Messner H; Schena F; Mosca F
    Clin Pharmacol Ther; 2012 Apr; 91(4):590-6. PubMed ID: 22089267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of patent ductus arteriosus ligation in very low birth weight premature infants: A retrospective cohort analysis.
    Ashfaq A; Rettig RL; Chong A; Sydorak R
    J Pediatr Surg; 2022 Jul; 57(7):1201-1204. PubMed ID: 35450698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Su PH; Chen JY; Su CM; Huang TC; Lee HS
    Pediatr Int; 2003 Dec; 45(6):665-70. PubMed ID: 14651538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial.
    Dang D; Wang D; Zhang C; Zhou W; Zhou Q; Wu H
    PLoS One; 2013; 8(11):e77888. PubMed ID: 24223740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting the effectiveness of oral ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
    Ye C; Lyu Q; Jiang L; Yu L; Xu Y; Zhang J; Lu X
    Int J Clin Pharm; 2021 Aug; 43(4):1074-1081. PubMed ID: 33400059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2011 Jul; (7):CD004213. PubMed ID: 21735396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.
    Sung SI; Chang YS; Chun JY; Yoon SA; Yoo HS; Ahn SY; Park WS
    J Pediatr; 2016 Oct; 177():66-71.e1. PubMed ID: 27453374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA).
    Mitra S; Jain A; Ting JY; Ben Fadel N; Drolet C; Abou Mehrem A; Soraisham A; Jasani B; Louis D; Lapointe A; Dorling J; Khurshid F; Hyderi A; Kumaran K; Bodani J; Weisz D; Alvaro R; Adie M; Stavel M; Morin A; Bhattacharya S; Kanungo J; Canning R; Ye XY; Hatfield T; Gardner CE; Shah P
    BMJ Open; 2021 May; 11(5):e050682. PubMed ID: 33952559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is ibuprofen superior to indomethacin for patent ductus arteriosus in Japanese preterm infants?
    Matsumura S; Masutani S; Oshima A; Kanai M; Namba F; Ishiguro A; Kabe K
    Pediatr Int; 2021 Aug; 63(8):929-934. PubMed ID: 33274573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?
    Olukman O; Calkavur S; Ercan G; Atlihan F; Oner T; Tavli V; Kultursay N
    Congenit Heart Dis; 2012; 7(6):534-43. PubMed ID: 22613269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.
    Varvarigou A; Bardin CL; Beharry K; Chemtob S; Papageorgiou A; Aranda JV
    JAMA; 1996 Feb; 275(7):539-44. PubMed ID: 8606475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and Safety of Oral Paracetamol vs. Oral Ibuprofen in the Treatment of Symptomatic Patent Ductus Arteriosus in Premature Infants.
    Karabulut B; Paytoncu S
    Paediatr Drugs; 2019 Apr; 21(2):113-121. PubMed ID: 31025304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.
    Erdeve O; Yurttutan S; Altug N; Ozdemir R; Gokmen T; Dilmen U; Oguz SS; Uras N
    Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F279-83. PubMed ID: 22147286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.